Editor's Note This study by researchers at La Jolla Institute for Immunology, La Jolla, California, finds that T cells fight SARS-CoV-2 by targeting a broad range of sites on the virus, beyond the key sites on the spike protein. By attacking the virus from many angles, the T cells can…
Editor's Note The Food & Drug Administration (FDA), on January 22, lowered the number of times an N95 mask can be cleaned and reused to 4, down from a previous maximum of 20 reuses, the January 25 Fierce Biotec reports. The FDA reissued emergency use authorizations for 10 N95 decontamination…
Editor's Note This survey of members of the Society for Pediatric Anesthesia finds that COVID-19 has affected the personal and professional lives of pediatric anesthesiologists, with women and non-whites disproportionately affected. Of 561 respondents: 21.7% planned to change their clinical responsibilities, and 10.6% planned to decrease their professional working time…
Editor's Note A Welltok survey of 1,000 adults across the US finds that 71% of employees are worried about COVID-19 vaccine side effects, 60% of Americans have a vaccine brand preference, and 52% are worried about the vaccine supply, the January 25 Human Resource Executive reports. Employers, who are seen…
Editor's Note This study, led by researchers from Johns Hopkins University School of Medicine, Baltimore, analyzed survey responses from 7,705 participants between April 1 and November 24, 2020, on their attitudes and resistance toward COVID-19 mitigation efforts. All US regions experienced decreases in COVID-19 mitigation efforts during this time period,…
Editor's Note The Food and Drug Administration on January 21 reissued emergency use authorizations (EUAs) for 10 systems used to decontaminate N95 respirators used by healthcare personnel . The 10 systems are: Michigan State University Decontamination System Technical Safety Services VHP Decontamination System Stryker Sustainability Solutions VHP Decontamination System STERIS…
Editor's Note From December 14 to 23, 2020, after administration of 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine, the Centers for Disease Control and Prevention (CDC) identified 21 case reports of anaphylaxis. Of those, 4 (19%) were hospitalized (including 3 in intensive care), and 17 (81%) were treated in…
Editor's Note A report from the Center for Healthcare Quality and Payment Reforms finds more than 800 rural hospitals—40% of rural hospitals in the US—are either at immediate or high risk of closure. The more than 300 rural hospitals at high risk of closure have low financial reserves or high…
Editor's Note A new negative-pressure ventilatory support device, similar to the “iron lung” used to treat polio patients in the 1950s, provides an additional treatment option for COVID-19 patients, finds this study by researchers in the UK’s Exovent Task Force, formed in March 2020 in response to the COVID-19 pandemic.…
Editor's Note A study, led by researchers from Rockefeller University in New York City, finds that volunteers vaccinated with either the Moderna or the Pfizer/BioNTech vaccine will be protected against new variants of the COVID-19 virus. The researchers tested plasma taken from 20 volunteers who had received both doses of…